A randomized trial of quilizumab in adults with refractory chronic spontaneous urticaria

J Allergy Clin Immunol. 2016 Dec;138(6):1730-1732. doi: 10.1016/j.jaci.2016.06.023. Epub 2016 Jul 19.
No abstract available

Publication types

  • Clinical Trial
  • Letter
  • Randomized Controlled Trial
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Anti-Allergic Agents / therapeutic use*
  • Chronic Disease
  • Double-Blind Method
  • Humans
  • Immunoglobulin E / metabolism
  • Omalizumab / therapeutic use*
  • Urticaria / drug therapy*
  • Urticaria / metabolism

Substances

  • Anti-Allergic Agents
  • Omalizumab
  • Immunoglobulin E